000 01434 a2200421 4500
005 20250518063735.0
264 0 _c20200708
008 202007s 0 0 eng d
022 _a1531-8257
024 7 _a10.1002/mds.27883
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMorales-BriceƱo, Hugo
245 0 0 _aLong-term safety and efficacy of 24-hour levodopa-carbidopa intestinal gel in Parkinson's disease.
_h[electronic resource]
260 _bMovement disorders : official journal of the Movement Disorder Society
_c11 2019
300 _a1747-1748 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAged
650 0 4 _aAntiparkinson Agents
_xtherapeutic use
650 0 4 _aCarbidopa
_xtherapeutic use
650 0 4 _aDrug Combinations
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLevodopa
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aParkinson Disease
_xdrug therapy
650 0 4 _aTreatment Outcome
700 1 _aMahant, Neil
700 1 _aHa, Ainhi D
700 1 _aChang, Florence C F
700 1 _aKim, Samuel D
700 1 _aGriffith, Jane
700 1 _aTsui, David
700 1 _aGalea, Donna
700 1 _aFung, Victor S C
773 0 _tMovement disorders : official journal of the Movement Disorder Society
_gvol. 34
_gno. 11
_gp. 1747-1748
856 4 0 _uhttps://doi.org/10.1002/mds.27883
_zAvailable from publisher's website
999 _c30192929
_d30192929